Pharmaceutical companies face demands on transparency and sustainability from their stakeholders. As they increasingly engage in programs to improve global health, critics claim that these initiatives aim only at improving access to medicinal products
Want our latest articles with fresh insights, trends and cases straight to your own inbox? Sign up today to get our inspirational newsletter – so you can do good & do well even better!